Shijiazhuang Pharmaceutical Group dl-3-butylphthalide Pharmaceutical Co. Ltd. Looking to the future and grace will Pu company will continue adhering to the CSPC good medicine, China "the enterprise idea, is committed to the cause of human health, to more, newer, more good
Drugs contributing to society, to the CSPC construction become the domestic first-class, international pharmaceutical industry 30 strong modern large-scale pharmaceutical enterprises and with their power.
Company was founded in 2003, the production area is located in Shijiazhuang economic and Technological Development Zone, covers an area of 150 acres, construction area of 30 thousand square meters, has a universal raw material medicine, soft capsule, injection, and other production lines. All production areas by the famous Medicines Co in the United States by the requirements of the United States FDA design, and was included in the national high-tech industrialization demonstration project and the focus of the project in Hebei province.
Company's main variety En will P R & D project has been included in the National Natural Science Fund project, 1035 project, the National 863 program, "Eighth Five Year Plan" and "Ninth Five Year" National Science and technology key project, "15" innovation and modernization of traditional Chinese medicine, a major science and technology projects, "Eleventh Five Year" major scientific and technological support to the project and the "Twelfth Five Year Plan" major science and technology projects. 2010, en Pu injection was rated as China's "ten new varieties of prescription drugs," the first. EN PU products have also been included in the "national health insurance directory", "the army's reasonable medical drug catalog", "China's acute ischemic stroke treatment guidelines 2010". Grace is surely Pu company currently has 20 national invention patent and 8 PCT patent and protected in dozens of countries and regions in the world, the company also successfully patent technology licensing Europe and the United States, South Korea and other markets, become China the first to patent license will drug the launch of the country's advanced representative.
EN Pu soft capsule and injection can be applied to the improvement of neurological deficits in patients with acute ischemic stroke. This product has a unique dual mechanism: the reconstruction of microcirculation, the protection of mitochondria. The experiment proved that the use of Tu Pu injection for 14 days, continue to take the soft capsule to 90 days, effectively reduce the disability, so that patients with greater benefit.
At present, the promotion of publicity: "reconstruction of the brain blood circulation to win the first time", and "reconstruction of the brain blood circulation protection of mitochondria", the two slogans.

產品展示

PRODUCT DISPALY

  • 恩必普·
     EN Pu soft capsule

    Dl-3-butylphthalide (Butylphthalide Soft Capsules)[functional indications]:Various pathological processes for the treatme
    MORE

  • 恩必普·
     Butylphthalide Soft Capsules Package Insert

    Butylphthalide Soft Capsules Package InsertPlease read the package insert carefully and please use the medicine und
    MORE

电影网_最新在线电影_韩国日本电影_爱情科幻电影_免费在线 https://www.1905.com/电影网 https://www.youku.com/优酷网 https://www.iqiyi.com/爱奇艺

小影视频,咪咕视频,成长视频在线观看免费

小影视频,七妹视频在线观看,成长视频在线观看免费

小影大全,天狼影院2019天狼影视大全,影视大全免费追剧

最新影视免费观看,最新电影

小影影视,三分钟免费观看视频,2345影视大全

小影视频,咪咕视频,成长视频在线观看免费

小影影视,天天影视,小小影视app

最新影视免费观看,最新影视推荐

小影影视,天天看高清影视在线观看,YY6080影视理论

最新影视免费观看,搞笑视频

已完结小说排行榜 盗墓笔记全集 怎么写网络小说 豆豆小说阅读网 《完美世界》txt全集 完美世界txt下载 完美世界官网 大主宰 有声小说在线收听网 玄幻小说完本